Compare VanEck Video Gaming and eSports ETF (ESPO) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
VanEck Video Gaming and eSports ETF vs Repligen Corporation Common Stock — how do they compare? VanEck Video Gaming and eSports ETF trades at $99.09 (market cap $256.17M), while Repligen Corporation Common Stock trades at $178.2 (market cap $11.31B). The key difference: Repligen Corporation Common Stock is far larger — about 44.2× VanEck Video Gaming and eSports ETF's market cap, and Repligen Corporation Common Stock is trading nearer its 52-week high, VanEck Video Gaming and eSports ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold VanEck Video Gaming and eSports ETF for 68 Days and Repligen Corporation Common Stock for 0 Days on average.
| ESPO | RGEN | |
|---|---|---|
Market Cap | $256.17M | $11.31B |
Volume | 15,265 | 1,216,919 |
Sector | Sector/Thematic | Health |
52-Week High | $116.66 | $194.57 |
52-Week Low | $85.25 | $102.87 |
Typical Hold Time | 68 Days | 0 Days |
Enterprise Value | — | $11.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ESPO trades at $100.43, up 0.08% today, with a bullish technical signal driven by strong moving average alignment. Key support lies at $97 and resistance at $98–$99. Financial ratios like P/E and P/S are unavailable in current data, limiting fundamental clarity. Recent news coverage is sparse, leaving sentiment largely neutral.
The stock's near-term outlook hinges on upcoming earnings to validate its technical strength. Risks include limited fundamental visibility and market volatility. Institutional positioning data is needed to gauge Wall Street confidence. Upside potential exists if resistance breaks, but caution is warranted without fresh catalysts.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About VanEck Video Gaming and eSports ETF
ESPO is a thematic ETF that invests in the global video gaming and eSports industry. It provides exposure to companies involved in game development, hardware, and streaming, including major firms like Tencent, Nintendo, and Electronic Arts.
Read more on ESPO →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
